Press Releases June 4, 2026 09:00 AM

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NEXGEL to present at Planet MicroCap Conference in Las Vegas, showcasing its medical and OTC hydrogel products

By Jordan Park NXGL

NEXGEL, Inc., a NASDAQ-listed company specializing in medical and over-the-counter hydrogel products, announced that CEO Adam Levy will present at the Planet MicroCap Conference in Las Vegas on June 16-18, 2026. The company highlights its longstanding expertise in electron-beam cross-linked hydrogels used in healthcare and consumer products and maintains strategic manufacturing partnerships.

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
NXGL

Key Points

  • NEXGEL CEO Adam Levy to present at Planet MicroCap Conference, increasing investor engagement.
  • Company specializes in ultra-gentle, high-water-content hydrogels for medical and OTC applications.
  • NEXGEL has well-established brands and strategic contract manufacturing relationships with major consumer healthcare companies.

LANGHORNE, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Planet MicroCap Conference on June 16 – 18, 2026, in Las Vegas, NV.

Planet MicroCap Las Vegas 2026
Dates: June 16-18, 2026
Location: Bellagio Hotel & Casino, Las Vegas, NV
Booth: #517
Presentation Day and Time: Wednesday, June 17, 2026, at 1:30 P.M. PT
Presentation Location: Track 3 - Da Vinci 3
Webcast: https://ir.nexgel.com/news-events/events-presentations

To schedule a one-on-one investor meeting with Mr. Levy, please contact KCSA Strategic Communications at [email protected].

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
[email protected]


Risks

  • Dependence on continued investor interest and ability to attract new capital at the conference.
  • Market competition in the healthcare and OTC product sectors which could affect growth.
  • Possible delays or challenges in contract manufacturing operations impacting revenue.

More from Press Releases

Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026 SOLV Energy Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares of Class A Common Stock Jun 4, 2026 NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option Jun 4, 2026